coIMMUNE, Inc.
Andrew Keen is an experienced professional in the field of quality control, currently serving as an Associate III in Quality Control Compliance at Biogen since March 2024. Prior to this role, Andrew worked as a Quality Control Analyst II at coIMMUNE, Inc., where responsibilities included conducting analytical testing and leading laboratory investigations. Andrew also held the position of Quality Control Analyst while gaining research experience as an Undergraduate Research Assistant at North Carolina State University, where experimental design and data analysis were key tasks. Earlier internships at Grifols and the North Carolina Department of Environmental Quality provided additional exposure to quality control processes and environmental monitoring. Andrew holds a Bachelor's degree in Microbiology and Biotechnology from North Carolina State University, earned in 2020.
coIMMUNE, Inc.
CoImmune is a cell therapy company designed to leverage its own immune system to fight disease. It is a clinical-stage immuno-oncology company that will redefine cancer treatment using best-in-class cellular immunotherapies.